![Differin® Gel Acne Treatment Partners with Actress Ashley Benson to End Adult Acne Frustrations for Millions of Sufferers Differin® Gel Acne Treatment Partners with Actress Ashley Benson to End Adult Acne Frustrations for Millions of Sufferers](https://mma.prnewswire.com/media/463301/Galderma_Differin_Product_Packaging.jpg?p=facebook)
Differin® Gel Acne Treatment Partners with Actress Ashley Benson to End Adult Acne Frustrations for Millions of Sufferers
Galderma Announces FDA Approval of Full Prescription-Strength Differin® Gel For Over-the-Counter Acne Use
![Rosacea Topical Treatment and Care: From Traditional to New Drug Delivery Systems | Molecular Pharmaceutics Rosacea Topical Treatment and Care: From Traditional to New Drug Delivery Systems | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.3c00324/asset/images/medium/mp3c00324_0003.gif)
Rosacea Topical Treatment and Care: From Traditional to New Drug Delivery Systems | Molecular Pharmaceutics
![Brimonidine tartrate gel plus topical steroid for the prevention of laser therapy‐related postinflammatory hyperpigmentation - Hong - 2018 - Dermatologic Therapy - Wiley Online Library Brimonidine tartrate gel plus topical steroid for the prevention of laser therapy‐related postinflammatory hyperpigmentation - Hong - 2018 - Dermatologic Therapy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6f7501f5-eacb-4704-b4ac-4d7386483838/dth.v31.5.cover.jpg?trick=1705046417209)
Brimonidine tartrate gel plus topical steroid for the prevention of laser therapy‐related postinflammatory hyperpigmentation - Hong - 2018 - Dermatologic Therapy - Wiley Online Library
![Galderma Receives FDA Approval of Mirvaso®: the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea | Business Wire Galderma Receives FDA Approval of Mirvaso®: the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea | Business Wire](https://mms.businesswire.com/media/20130826005515/en/379985/5/Galderma_BeforeAfter%23135C49.jpg)
Galderma Receives FDA Approval of Mirvaso®: the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea | Business Wire
![In vivo, micro‐morphological vascular changes induced by topical brimonidine studied by Dynamic optical coherence tomography - Themstrup - 2016 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library In vivo, micro‐morphological vascular changes induced by topical brimonidine studied by Dynamic optical coherence tomography - Themstrup - 2016 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a7551642-0006-4a38-ad27-53739403af78/jdv.2016.30.issue-6.cover.jpg?trick=1694741008362)
In vivo, micro‐morphological vascular changes induced by topical brimonidine studied by Dynamic optical coherence tomography - Themstrup - 2016 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
Updates and Best Practices in the Management of Facial Erythema. - Document - Gale OneFile: Health and Medicine
![Galderma Laboratories Announces Availability of New Mirvaso® (brimonidine) Topical Gel, 0.33%* Pump Dispenser for the Treatment of the Persistent Facial Redness of Rosacea | Business Wire Galderma Laboratories Announces Availability of New Mirvaso® (brimonidine) Topical Gel, 0.33%* Pump Dispenser for the Treatment of the Persistent Facial Redness of Rosacea | Business Wire](https://mms.businesswire.com/media/20160519005305/en/525692/4/2569295_Mirvaso_Logo.jpg)
Galderma Laboratories Announces Availability of New Mirvaso® (brimonidine) Topical Gel, 0.33%* Pump Dispenser for the Treatment of the Persistent Facial Redness of Rosacea | Business Wire
![Improving Treatment of Erythematotelangiectatic Rosacea with Laser and/or Topical Therapy Through Enhanced Discrimination of its Clinical Features. - Abstract - Europe PMC Improving Treatment of Erythematotelangiectatic Rosacea with Laser and/or Topical Therapy Through Enhanced Discrimination of its Clinical Features. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5023001/bin/jcad_9_7_30-g007c.jpg)
Improving Treatment of Erythematotelangiectatic Rosacea with Laser and/or Topical Therapy Through Enhanced Discrimination of its Clinical Features. - Abstract - Europe PMC
![Rosacea Topical Treatment and Care: From Traditional to New Drug Delivery Systems | Molecular Pharmaceutics Rosacea Topical Treatment and Care: From Traditional to New Drug Delivery Systems | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.3c00324/asset/images/medium/mp3c00324_0001.gif)
Rosacea Topical Treatment and Care: From Traditional to New Drug Delivery Systems | Molecular Pharmaceutics
Updates and Best Practices in the Management of Facial Erythema. - Document - Gale OneFile: Health and Medicine
Galderma Receives FDA Approval to Market Restylane® Lyft with Lidocaine to Correct Age Related Volume Loss in the Cheek Area
![Brimonidine tartrate gel plus topical steroid for the prevention of laser therapy‐related postinflammatory hyperpigmentation - Hong - 2018 - Dermatologic Therapy - Wiley Online Library Brimonidine tartrate gel plus topical steroid for the prevention of laser therapy‐related postinflammatory hyperpigmentation - Hong - 2018 - Dermatologic Therapy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e7b461f4-55bd-4621-9fa4-50597507f042/dth12657-fig-0001-m.jpg)
Brimonidine tartrate gel plus topical steroid for the prevention of laser therapy‐related postinflammatory hyperpigmentation - Hong - 2018 - Dermatologic Therapy - Wiley Online Library
Updates and Best Practices in the Management of Facial Erythema. - Document - Gale OneFile: Health and Medicine
![Improving Treatment of Erythematotelangiectatic Rosacea with Laser and/or Topical Therapy Through Enhanced Discrimination of its Clinical Features. - Abstract - Europe PMC Improving Treatment of Erythematotelangiectatic Rosacea with Laser and/or Topical Therapy Through Enhanced Discrimination of its Clinical Features. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5023001/bin/jcad_9_7_30-g001.jpg)